News & Perspective

Jan 10, 2020

Jan 10, 2020

ASP Scan (Weekly) for Jan 10, 2020

AMR gene tracking kit
Diagnostics for respiratory infections
Carbapenemase containment plan
Hypervirulent, carbapenem-resistant Klebsiella
Funds for new class of superbug drugs
CARB-X funds for novel immunotherapy
Co-prescribing of antibiotics, asthma drugs
Pediatric stewardship review
Carbapenem resistance in Egyptian hospitals
Targeted C diff reduction

Sep 06, 2019

Sep 06, 2019

ASP Scan (Weekly) for Sep 06, 2019

Resistance rates and income
Assessing national stewardship programs
Antibiotics on citrus trees
Telehealth-based stewardship
Pharmacist-led outpatient stewardship
VRE risks in C diff treatment
Cultural influence on prescribing
Group A strep vaccine candidate
Value of pre-op urine tests
Stewardship training for medical residents

Jun 30, 2017

Jun 30, 2017

ASP Scan (Weekly) for Jun 30, 2017

Students' antibiotic knowledge
MCR-1 in Portugal
Opposition to AMR budget cuts
Antibiotics for skin wounds
Antibiotic resistance at the Hajj
C diff in cancer patients
Contact precautions for MRSA
Antibiotic-resistant acne

Apr 21, 2017

Apr 21, 2017

ASP Scan (Weekly) for Apr 21, 2017

Marker for pneumonia antibiotics
MCR-1 cases in Italy
Novel antibiotic target
Penicillin-resistant pneumonia
ID stewardship consults
Steroid for sore throat
MRSA contamination
Chlorhexidine bathing
Candida in Peru
Azithromycin and abnormal heartbeat
Mutations in resistant bacteria

Feb 03, 2009

Feb 03, 2009

Experts weigh new H5N1 vaccine strategies

(CIDRAP News) – At an Infectious Diseases Society of America (IDSA) symposium in Washington, DC, today on seasonal and pandemic influenza, a group of experts fielded questions from reporters on some of the new trends and emerging issues, including prepandemic strategies for H5N1 avian influenza vaccines, now that some countries are stockpiling them.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»